Cargando…

The role of IL-6 and osteoprotegerin in bone metabolism in patients with Graves’ disease

BACKGROUND/AIM: Increased bone turnover is a hallmark of hyperthyroidism. The underlying factors of how thyroid hormones affect bone cells are still under the spotlight. Previous studies indicated serum osteoprotegerin (OPG), receptor activator of NF-kB ligand (RANKL), and interleukin-6 (IL-6) as me...

Descripción completa

Detalles Bibliográficos
Autores principales:	OMMA, Tülay, YÜCEL, Çiğdem, SERTOĞLU, Erdim, FIRAT, Sevde Nur, ÇULHA, Cavit, ÖZGÜRTAŞ, Taner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific and Technological Research Council of Turkey (TUBITAK) 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381196/ https://www.ncbi.nlm.nih.gov/pubmed/36161625 http://dx.doi.org/10.3906/sag-2105-1

Ejemplares similares

Evaluation of atherogenic laboratory markers in Behçet’s disease patients with vascular involvement
por: Yücel, Çiğdem, et al.
Publicado: (2019)

Pedabarography May Play a Role in Foot Plantar Scanning in Acromegaly
por: Omma, Tulay, et al.
Publicado: (2022)

Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19
por: Sertoglu, Erdim, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in different etiological causes of thyrotoxicosis
por: TAŞKALDIRAN, Işılay, et al.
Publicado: (2019)

Accurate use of neutrophil/lymphocyte ratio from the perspective of laboratory experts
por: Sertoglu, Erdim, et al.
Publicado: (2013)

Importance of the Selected Cut-Offs for Serum Uric Acid and Lipids Levels
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Plasma Total Homocysteine Levels in Diabetic Retinopathy
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Value of neutrophil to lymphocyte ratio as a biomarker in colorectal adenocarcinoma
por: Sertoglu, Erdim, et al.
Publicado: (2016)

Biochemical view on: Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes
por: Kayadibi, Huseyin, et al.
Publicado: (2015)

Comment on “Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio: Novel Markers for Diagnosis and Prognosis in Patients with Idiopathic Sudden Sensorineural Hearing Loss”
por: Sertoglu, Erdim, et al.
Publicado: (2015)

The Evaluation of the Neutrophil-to-Lymphocyte Ratio in Coronary Chronic Total Occlusion
por: Sertoglu, Erdim, et al.
Publicado: (2015)

Study of Correlation between Serum Osteoprotegerin, TNF-Alfa, and Biomarkers of Bone Metabolism in Patients with Treatment-Naive Graves’ Disease—A Cross-Sectional Study
por: Behera, Kishore, et al.
Publicado: (2023)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

Osteoprotegerin in Bone Metastases: Mathematical Solution to the Puzzle
por: Ryser, Marc D., et al.
Publicado: (2012)

Osteoprotegerin in breast cancer: beyond bone remodeling
por: Weichhaus, Michael, et al.
Publicado: (2015)

Bone Turnover Markers and Osteoprotegerin in Uncomplicated Pregnancy
por: Styczynska, Hanna, et al.
Publicado: (2009)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption
por: Cawley, Keisha M., et al.
Publicado: (2020)

Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin
por: Priadko, Kateryna, et al.
Publicado: (2022)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
por: Şimşek, Tülay, et al.
Publicado: (2017)

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003)

In vitro evaluation of osteoprotegerin in chitosan for potential bone defect applications
por: Jayash, Soher Nagi, et al.
Publicado: (2016)

The Effect of Orthognathic Surgery on Osteoprotegerin as Immunological Caliper of Bone Healing
por: Soliman, Sara, et al.
Publicado: (2016)

The roles of osteoprotegerin in cancer, far beyond a bone player
por: Wang, Yufei, et al.
Publicado: (2022)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
por: Jawiarczyk-Przybyłowska, Aleksandra, et al.
Publicado: (2022)

Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009)

The role of osteoprotegerin in arthritis
por: Schett, Georg, et al.
Publicado: (2003)

Osteoprotegerin in Cardiometabolic Disorders
por: Pérez de Ciriza, C., et al.
Publicado: (2015)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin
por: Wu, Colleen, et al.
Publicado: (2015)

Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone
por: Wang, Baoli, et al.
Publicado: (2015)

Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone
por: Ulivieri, F. M., et al.
Publicado: (2006)

Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet’s disease
por: Omma, Ahmet, et al.
Publicado: (2018)

The effect of colostrum intake on osteoprotegerin and bone metabolic markers in the blood of newborn calves during the first week of life
por: HATATE, Kaoru, et al.
Publicado: (2018)

Plasma Free Fatty Acids in Hyperemesis Gravidarum Pregnancy
por: Ulubay, Mustafa, et al.
Publicado: (2017)

Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease: Associations with laboratory findings, comorbidities, and medications
por: Erturk, Ismail, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3khmpbsr8phlh31pl9ntbpp1ki